Drugs / Gingko Biloba
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02181972 | May → Nov 2002 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01544192 Comparator | Apr 2008 → Nov 2009 | glaucoma | Bagcilar Training and Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gingko Biloba | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01544192 ↗ |
| Route | Oral | “2 x 60 mg Daily p.o.” NCT02181972 ↗ |